AstraZeneca challenges Aurobindo’s proposed Nexium generic

17-12-2013

AstraZeneca has sued Aurobindo Pharma Limited and its US-based subsidiary Aurobindo Pharma USA Inc for infringing four of its patents related to heartburn drug Nexium.


LSIPR